Houston Methodist Hospital is the flagship quaternary care hospital of Houston Methodist academic medical center.

There are 924 beds in Houston Methodist Hospital.

During the past decade, Houston Methodist Hospital conducted 436 clinical trials. In the 10-year time frame, 436 clinical trials started and 233 clinical trials were completed, i.e. on average, 53.4% percent of trials that started reached the finish line to date. In the past 5 years, 182 clinical trials started and 157 clinical trials were completed. i.e. 86.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Houston Methodist Hospital" #1 sponsor was "Baylor College of Medicine" with 91 trials, followed by "National Cancer Institute (NCI)" with 46 trials sponsored, "The Methodist Hospital Research Institute" with 38 trials sponsored, "Abbott Medical Devices" with 23 trials sponsored and "SWOG Cancer Research Network" with 23 trials sponsored. Other sponsors include 528 different institutions and companies that sponsored additional 320 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Houston Methodist Hospital" #1 collaborator was "The Methodist Hospital Research Institute" with 120 trials as a collaborator, "Center for Cell and Gene Therapy, Baylor College of Medicine" with 81 trials as a collaborator, "National Cancer Institute (NCI)" with 64 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 14 trials as a collaborator. Other collaborators include 384 different institutions and companies that were collaborators in the rest 256 trials.

According to Clinical.Site data, the most researched conditions in "Houston Methodist Hospital" are "Coronary Artery Disease" (22 trials), "Breast Cancer" (20 trials), "Atrial Fibrillation" (14 trials), "Pulmonary Arterial Hypertension" (14 trials) and "Heart Failure" (13 trials). Many other conditions were trialed in "Houston Methodist Hospital" in a lesser frequency.

Most popular intervention types in "Houston Methodist Hospital" are "Drug" (397 trials), "Device" (190 trials), "Biological" (145 trials), "Other" (145 trials) and "Procedure" (74 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (98 trials), "Laboratory Biomarker Analysis" (49 trials), "Quality-of-Life Assessment" (35 trials), "Paclitaxel" (29 trials) and "Carboplatin" (23 trials). Other intervention names were less common.

The vast majority of trials in "Houston Methodist Hospital" are 670 trials for "All" genders, 71 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are 270 active trials in "Houston Methodist Hospital". 5 are not yet recruiting, 137 are recruiting, 121 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 330 completed trials in Houston Methodist Hospital, 5 suspended trials, and 101 terminated clinical trials to date.

Out of the total trials that were conducted in Houston Methodist Hospital, 118 "Phase 1" clinical trials were conducted, 190 "Phase 2" clinical trials and 223 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 34 trials, and there were also 153 trials that are defined as “Not Applicable".

Houston Methodist Hospital has several departments that took part in Clinical trials: "Houston Methodist Cancer Center" - 55 trials, "Houston Methodist Neurological Institute" - 53 trials, "Methodist DeBakey Heart Center" - 23 trials, "Houston Sleep Center" - 7 trials, "Bone & Joint Clinic of Houston" - 5 trials, "Houston Methodist Neurological Institute/Movement Disorders Clinic (135)" - 4 trials, "Methodist DeBakey Cardiology Associates" - 2 trials, "Methodist Urology Associates" - 2 trials, "Methodist Neurological Institute - Department of Neurosurgery" - 2 trials